SmithKline Beecham
Executive Summary
Jan Leschly ascends to CEO following official retirement of Robert Bauman at the company's annual meeting. Leschly had been running the company's worldwide prescription drug business as chairman of SmithKline Beecham Pharmaceuticals, a position that Jean-Pierre Garnier, the former head of SB's North American drug business, takes over. The planned transition was first announced a year ago at the company's annual meeting ("The Pink Sheet" May 3, 1993, T&G-9)